erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Diseases D008107 31 associated lipids
Long QT Syndrome D008133 10 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Cutaneous D008178 2 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lyme Disease D008193 5 associated lipids
Lymphadenitis D008199 8 associated lipids
Lymphangitis D008205 4 associated lipids
Lymphogranuloma Venereum D008219 4 associated lipids
Mycetoma D008271 4 associated lipids
Marfan Syndrome D008382 2 associated lipids
Mastoiditis D008417 2 associated lipids
Maxillofacial Injuries D008446 1 associated lipids
Megacolon D008531 1 associated lipids
Meningitis, Haemophilus D008583 3 associated lipids
Meningitis, Listeria D008584 1 associated lipids
Microphthalmos D008850 1 associated lipids
Stomatognathic Diseases D009057 1 associated lipids
Multiple Myeloma D009101 13 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Mycoplasmatales Infections D009180 6 associated lipids
Myiasis D009198 1 associated lipids
Nasal Polyps D009298 26 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Nasopharyngitis D009304 2 associated lipids
Nausea D009325 7 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nervous System Diseases D009422 37 associated lipids
Hereditary Sensory and Autonomic Neuropathies D009477 1 associated lipids
Neutropenia D009503 15 associated lipids
Nocardia Infections D009617 6 associated lipids
Obesity D009765 29 associated lipids
Endophthalmitis D009877 12 associated lipids
Ophthalmia Neonatorum D009878 1 associated lipids
Psittacosis D009956 4 associated lipids
Orthomyxoviridae Infections D009976 3 associated lipids
Osteitis D010000 10 associated lipids
Osteolysis D010014 8 associated lipids
Osteomyelitis D010019 10 associated lipids
Otitis D010031 5 associated lipids
Otitis Externa D010032 8 associated lipids
Otitis Media D010033 12 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Otitis Media, Suppurative D010035 4 associated lipids
Otorhinolaryngologic Diseases D010038 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Rampe D and Murawsky MK Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycin. 1997 Naunyn Schmiedebergs Arch. Pharmacol. pmid:9205959
Gleason PP et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. 1997 JAMA pmid:9207335
Lagasse JP et al. [Acute reversible pan-dysautonomia: effect of erythromycin on gastrointestinal involvement]. 1997 Gastroenterol. Clin. Biol. pmid:9208000
Vagliasindi M Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin. 1997 Int J Clin Pharmacol Ther pmid:9208340
Nakamura A [Prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in a children's hospital]. 1997 Kansenshogaku Zasshi pmid:9209123
Nakata K et al. [Suppressive effect of clarithromycin on the production of verotoxin by E. coli O157]. 1997 Kansenshogaku Zasshi pmid:9209125
Kluger MT Erythromycin--a pro-kinetic and pro-arrhythmogenic agent. 1997 Anaesth Intensive Care pmid:9209631
Itoh Z Motilin and clinical application. 1997 Peptides pmid:9210180
Tenson T et al. Erythromycin resistance peptides selected from random peptide libraries. 1997 J. Biol. Chem. pmid:9211885
Kudoh S [Pathophysiology of diffuse panbronchiolitis and progress of the therapy]. 1996 Nihon Kyobu Shikkan Gakkai Zasshi pmid:9216178
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Annese V et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. 1997 Aliment. Pharmacol. Ther. pmid:9218089
Hoppe JE and Tschirner T Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis. 1997 Diagn. Microbiol. Infect. Dis. pmid:9218920
Antsaklis A et al. Erythromycin treatment for subclinical Ureaplasma urealyticum infection in preterm labor. 1997 Mar-Apr Fetal. Diagn. Ther. pmid:9218948
Jacobsen JR et al. Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. 1997 Science pmid:9219693
Hanson MR and Bogorad L Effects of erythromycin on membrane-bound chloroplast ribosomes from wild-type Chlamydomonas reinhardi and erythromycin-resistant mutants. 1977 Biochim. Biophys. Acta pmid:921999
Gaudreau C and Gilbert H Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. 1997 J. Antimicrob. Chemother. pmid:9222038
Onody C et al. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila. 1997 J. Antimicrob. Chemother. pmid:9222053
Sefton AM et al. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria. 1997 J. Antimicrob. Chemother. pmid:9222071
Handsfield HH Azithromycin in gonorrhoea. 1997 Int J STD AIDS pmid:9228599
Kobayashi T et al. Ototoxic effect of erythromycin on cochlear potentials in the guinea pig. 1997 Ann. Otol. Rhinol. Laryngol. pmid:9228863
Takizawa H et al. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. 1997 Am. J. Respir. Crit. Care Med. pmid:9230759
Fisman S et al. Erythromycin interaction with risperidone or clomipramine in an adolescent. 1996 J Child Adolesc Psychopharmacol pmid:9231305
Oesterheld JR Erythromycin and clomipramine: noncompetitive inhibition of demethylation. 1996 J Child Adolesc Psychopharmacol pmid:9231314
Seppälä H et al. Erythromycin resistance of group A streptococci from throat samples is related to age. 1997 Pediatr. Infect. Dis. J. pmid:9239768
Herdy GV et al. [Secondary prophylaxis in rheumatic fever. Oral antibiotic therapy versus benzathine penicillin]. 1996 Arq. Bras. Cardiol. pmid:9239868
Altomare DF et al. Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer. 1997 Br J Surg pmid:9240156
Berk SL Therapy for severe community-acquired pneumonia. 1997 Clin. Infect. Dis. pmid:9243063
Hofstetter A et al. [Treatment of chlamydial urethro-adnexitis with erythromycin]. 1977 Fortschr. Med. pmid:924327
Rapoport N et al. Factors affecting the permeability of Pseudomonas aeruginosa cell walls toward lipophilic compounds: effects of ultrasound and cell age. 1997 Arch. Biochem. Biophys. pmid:9244388
Pereda A et al. Nucleotide sequence of the ermE distal flank of the erythromycin biosynthesis cluster in Saccharopolyspora erythraea. 1997 Gene pmid:9249068
Bonnefoy A et al. Ketolides lack inducibility properties of MLS(B) resistance phenotype. 1997 J. Antimicrob. Chemother. pmid:9249208
Barry AL et al. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. 1997 J. Antimicrob. Chemother. pmid:9249220
Seppälä H et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. 1997 N. Engl. J. Med. pmid:9250845
Swartz MN Use of antimicrobial agents and drug resistance. 1997 N. Engl. J. Med. pmid:9250853
Ridlen JS et al. Determination of erythromycin in urine and plasma using microbore liquid chromatography with tris(2,2'-bipyridyl)ruthenium(II) electrogenerated chemiluminescence detection. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9252054
Goossens C et al. Baboon syndrome. 1997 Dermatology (Basel) pmid:9252782
Peterson LR et al. Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics. 1977 J. Infect. Dis. pmid:925383
Boyer PJ Outbreak of clinical mastitis in dairy cows following 'blitz' therapy. 1997 Vet. Rec. pmid:9253837
Schugk J et al. A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. 1997 Scand. J. Infect. Dis. pmid:9255881
Baty V et al. Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host. 1997 Scand. J. Infect. Dis. pmid:9255901
Brunke KJ et al. A technique for the rapid selection of drug-sensitive and auxotrophic mutants of Phycomyces blakesleeanus. 1977 J. Gen. Microbiol. pmid:925680
Rouse MS et al. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. 1997 Antimicrob. Agents Chemother. pmid:9257739
Fuursted K Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension. 1997 Antimicrob. Agents Chemother. pmid:9257743
Ogasawara KK and Goodwin TM The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. 1997 Am J Perinatol pmid:9259934
Dajani AS et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. 1997 J Am Dent Assoc pmid:9260427
Szklarz GD and Halpert JR Molecular modeling of cytochrome P450 3A4. 1997 J. Comput. Aided Mol. Des. pmid:9263853
Sorkine P et al. Gut decontamination reduces bowel ischemia-induced lung injury in rats. 1997 Chest pmid:9266889
Cazzola M et al. A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease. 1997 J Chemother pmid:9269609
Takahashi Y et al. Effects of indomethacin, dexamethasone, and erythromycin on endotoxin-induced intraepithelial mucus production of rat nasal epithelium. 1997 Ann. Otol. Rhinol. Laryngol. pmid:9270434